Cory Kasimov
Stock Analyst at Evercore ISI Group
(3.79)
Main Sectors:
33 Stocks
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
CYTK Cytokinetics | Maintains: Outperform | 60 80 | 56.97 | 40.42% | 1 | Sep 3, 2025 | |
VIR Vir Biotechnology | Initiates Coverage On: Outperform | 12 | 5.73 | 109.42% | 1 | Sep 3, 2025 | |
IMNM Immunome | Initiates Coverage On: Outperform | 18 | 12.38 | 45.4% | 1 | Aug 22, 2025 | |
SMMT Summit Therapeutics | Maintains: Outperform | 30 34 | 21.43 | 58.66% | 2 | Aug 12, 2025 | |
XENE Xenon Pharmaceutical... | Initiates Coverage On: Outperform | 55 | 39.61 | 38.85% | 1 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: In-Line | 50 32 | 28.49 | 12.32% | 6 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 190 185 | 137.03 | 35.01% | 2 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 60 65 | n/a | n/a | 2 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 45 50 | 52.86 | -5.41% | 3 | Dec 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 45 50 | 15.65 | 219.49% | 2 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 110 125 | 105.49 | 18.49% | 4 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 115 105 | 55.43 | 89.43% | 10 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 1250 1175 | 600 | 95.83% | 5 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 85 | 85.07 | -0.08% | 1 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 84 88 | 31.21 | 181.96% | 5 | Feb 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 260 250 | n/a | n/a | 2 | Jun 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 50 | n/a | n/a | 1 | Jan 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 324 276 | 159.88 | 72.63% | 3 | Dec 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 35 | 3.96 | 783.84% | 1 | Mar 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 1520 780 | n/a | n/a | 3 | Feb 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 225 232 | 297.89 | -22.12% | 5 | Jul 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 4 | May 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 1 | May 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 168 163 | n/a | n/a | 2 | Apr 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 25 21 | 31.06 | -32.39% | 2 | Feb 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | n/a | n/a | n/a | 4 | Nov 14, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 83 23 | 5.13 | 348.34% | 6 | Nov 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 71 16 | n/a | n/a | 8 | Oct 31, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 60 63 | n/a | n/a | 5 | May 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Overweight | 110 | n/a | n/a | 2 | Mar 21, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | n/a | n/a | n/a | 4 | Feb 14, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 15 10 | 1.41 | 609.22% | 1 | Feb 14, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 310 250 | 10.1 | 2375.25% | 1 | Feb 14, 2018 |